These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10492804)

  • 1. Delayed-type hypersensitivity reactions to Onchocerca volvulus antigens in exposed and non-exposed African individuals.
    Burchard GD; Brattig NW; Kruppa TF; Horstmann RD
    Trans R Soc Trop Med Hyg; 1999; 93(1):103-5. PubMed ID: 10492804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
    Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
    Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
    Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
    Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous pathology in onchocerciasis associated with pronounced systemic T-helper 2-type responses to Onchocerca volvulus.
    Timmann C; Abraha RS; Hamelmann C; Buttner DW; Lepping B; Marfo Y; Brattig N; Horstmann RD
    Br J Dermatol; 2003 Oct; 149(4):782-7. PubMed ID: 14616370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions.
    Lustigman S; MacDonald AJ; Abraham D
    Int J Parasitol; 2003 Sep; 33(11):1161-71. PubMed ID: 13678632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.
    Turaga PS; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2000 Apr; 68(4):1905-11. PubMed ID: 10722581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
    Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
    Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.
    Pfaff AW; Kirch AK; Hoffmann WH; Banla M; Schulz-Key H; Geiger SM; Soboslay PT
    Parasite Immunol; 2003 Jun; 25(6):325-32. PubMed ID: 14507330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of histamine release in parasitized individuals by somatic and cuticular antigens from Onchocerca volvulus.
    González-Muñoz M; Gárate T; Puente S; Subirats M; Moneo I
    Am J Trop Med Hyg; 1999 Jun; 60(6):974-9. PubMed ID: 10403330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of ES-62 to inhibit T-helper type 1 responses to other filarial nematode antigens.
    Al-Riyami L; Egan CA; Bradley JE; Lustigman S; Harnett W
    Parasite Immunol; 2008 May; 30(5):304-8. PubMed ID: 18312502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune recognition of Onchocerca volvulus proteins in the human host and animal models of onchocerciasis.
    Manchang TK; Ajonina-Ekoti I; Ndjonka D; Eisenbarth A; Achukwi MD; Renz A; Brattig NW; Liebau E; Breloer M
    J Helminthol; 2015 May; 89(3):375-86. PubMed ID: 24721822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.
    Cho-Ngwa F; Liu J; Lustigman S
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e800. PubMed ID: 20808763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients.
    Tawill SA; Gallin M; Erttmann KD; Kipp W; Bamuhiiga J; Büttner DW
    Trans R Soc Trop Med Hyg; 1996; 90(1):85-9. PubMed ID: 8730320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human immune responses to the cytosolic superoxide dismutase and glutathione S-transferase from Onchocerca volvulus.
    Brattig NW; Henkle-Dührsen KH; Hounkpatin S; Liebau E; Kruppa TF; Zipfel PF
    Trop Med Int Health; 1997 Aug; 2(8):788-98. PubMed ID: 9294549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus.
    Elson LH; Calvopiña M; Paredes W; Araujo E; Bradley JE; Guderian RH; Nutman TB
    J Infect Dis; 1995 Mar; 171(3):652-8. PubMed ID: 7876612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar blackfly attraction by onchocerciasis patients and individuals putatively immune to Onchocerca volvulus.
    Kruppa TF; Burchard GD
    Trans R Soc Trop Med Hyg; 1999; 93(4):365-7. PubMed ID: 10674077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
    Hoerauf A; Brattig N
    Trends Parasitol; 2002 Jan; 18(1):25-31. PubMed ID: 11850011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.